BioNTech: 100 Million Doses of COMIRNATY for the EU
NEW YORK / MAINZ – Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a … Continue reading BioNTech: 100 Million Doses of COMIRNATY for the EU
CureVac: Over 100 Million vaccines to be produced
TÜBINGEN – CureVac N.V. (Nasdaq: CVAC), a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) and Celonic Group, a premium biopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in the development and production … Continue reading CureVac: Over 100 Million vaccines to be produced
EMA Approves BioNTech Storage Option for EU
NEW YORK/MAINZ – Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Medicines Agency (EMA) approved storage of COMIRNATY® at -25°C to -15°C for a total of two weeks based on data showing the stability at these temperatures in … Continue reading EMA Approves BioNTech Storage Option for EU
Philippines receives 13 Million Doses of Vaccine
CAMBRIDGE, Mass. – Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a supply agreement with the Government of The Philippines for 13 million doses of the COVID-19 Vaccine Moderna. Under the terms … Continue reading Philippines receives 13 Million Doses of Vaccine